Merck job cuts mean the drugmaker is slashing about 20 percent of its workforce. 8,500 jobs will be added to the 7,500 Merck job cuts already announced, bringing the total to 16,000. Continue reading
The number of new drugs approved per billion US dollars spent on R&D by the pharmaceutical industry fell by half roughly every 9 years since 1950 Continue reading
Pfizer Inc. PFE +0.18% plans to shrink certain segments of its U.S. sales force, in the drug maker’s latest cost-cutting move. Pfizer spokesman MacKay Jimeson said Friday the sales force would be reduced, but didn’t quantify the scope of the cuts. “As part of our strategy to allocate our resources, investments and people to the … Continue reading
Swiss pharmaceuticals giant Novartis has arranged a crisis meeting of scientists, NHS trustees and Government officials starting today in London in a bid to streamline Britain’s “haphazard” approach to medical research and development (R&D). Science Minister David Willetts is due to attend the meeting, thought to be the first to unite representatives of Big Pharma … Continue reading
Ameridose LLC, an affiliate of the drug-compounding pharmacy at the center of a deadly fugal meningitis outbreak in the United States, is cutting 650 positions as it grapples with an indefinite closure following regulatory scrutiny of its sterilization practices. According to the Boston Globe, Ameridose employees have been notified of their pending termination from the … Continue reading
A spokeswoman for Abbott Laboratories says the announcement Wednesday of a 550-job reduction in the drug and health care products company’s worldwide workforce will not have an impact on its nutrition products facility in Sturgis. But she said there will be some impact in Sturgis over the next year. That is part of an announcement … Continue reading
Actelion Ltd. (ATLN) plans to cut 135 jobs and refocus research on rare diseases and specialty pharmaceuticals as sales decline for the company’s best-selling product, the Tracleer blood-pressure drug. The cost savings will reduce research spending, and some projects will be stopped, the Allschwil, Switzerland-based company said in a statement today. Actelion will take a … Continue reading
Drugmaker Sanofi plans to cut 1,000 to 2,000 jobs in France, according to French daily Le Figaro, the latest in a series of cost-cutting moves at the company, some of whose key drugs face increased competition from generic rivals. The jobs targetted will be in the areas of research, the manufacturing operations of the company’s … Continue reading
German drugs and chemicals group Merck KGaA announced plans on Friday for a cost-cutting programme across all its businesses that may include job cuts. “Over the next two years Merck needs to address unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization to ensure the long-term success of … Continue reading
Profits at pharmaceutical companies have been declining or showing little growth for the last year as austerity measures across Europe lead to cuts in health care spending. Some analysts say this trend could continue until at least 2014. Budget cuts mean that many European governments are not willing to pay as much for pills. But … Continue reading